Johnson & Johnson in $2.2B settlement over improperly marketing drugs

By CNN Staff

Mon November 4, 2013

(CNN) — Health care manufacturer Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil investigations over allegations that they marketed three drugs for uses that were never approved, U.S. Attorney General Eric Holder said Monday in Washington.

The settlements also cover claims that the companies gave “kickbacks” to physicians and to nursing home pharmacies to promote the drugs’ usage.

The claims involve the drugs Risperdal, Invega and Natrecor.

Holder said Johnson & Johnson improperly marketed the drug Risperdal for treatment of psychotic symptoms in elderly, non-schizophrenic patients, even though the drug was approved only to treat schizophrenia.

He said Rispidol and Invega also were improperly marketed for dementia treatment.

That led insurance companies to pay for claims they never should have been paying, he said.

“(The companies) lined their pockets at the expense of American taxpayers (and) patients,” Holder said.


Tags: , , , ,

One Response to “Johnson & Johnson in $2.2B settlement over improperly marketing drugs”

  1. gregdougall Says:

    “A family company”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: